Matches in SemOpenAlex for { <https://semopenalex.org/work/W27008307> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- W27008307 endingPage "53" @default.
- W27008307 startingPage "247" @default.
- W27008307 abstract "To investigate the effects of rosuvastatin on monocrotaline (MCT)-induced pulmonary artery hypertension in rats.Pulmonary arterial hypertension was induced by a single subcutaneous injection of monocrotaline (50 mg/kg) in rats. In the prevention protocol, 32 male Sprague-Dawley rats were randomly divided into four groups (n = 8 each): low-dose rosuvastatin prevention group (2 mg×kg(-1)×d(-1)), high-dose rosuvastatin prevention group (10 mg×kg(-1)×d(-1)), pulmonary arterial hypertension group, normal control group. Beginning on the MCT injection day, rats were treated with rosuvastatin by daily gavage for 4 weeks. Normal control group and pulmonary arterial hypertension group received vehicle by gavage. In the treatment protocol, 52 male Sprague-Dawley rats were randomly divided into four groups (n = 13 each): low-dose rosuvastatin treatment group (2 mg×kg(-1)×d(-1)), high-dose rosuvastatin treatment group (10 mg×kg(-1)×d(-1)), pulmonary arterial hypertension group, normal control group. Four weeks after MCT injection, rats were treated with rosuvastatin by daily gavage for 4 weeks. Normal control group and pulmonary arterial hypertension group received vehicle by gavage. At the end of study, survival rates, mean pulmonary arterial pressure (mPAP), wall thickness of small pulmonary artery and right ventricular hypertrophy among groups were compared. The expression levels of proliferating cell nuclear antigen (PCNA) and endothelial nitricoxide synthase (eNOS) protein in small pulmonary artery, the expression levels of Rho kinase 1(ROCK-1) and eNOS mRNA in lung tissue were also detected.All rats in the prevention protocol survived. Rosuvastatin treatment improved survival in the treatment protocol (58%, 75% vs.30%, P < 0.05). Rosuvastatin therapy in both preventive or treatment protocols significantly lowered mPAP [prevention protocol: (27.53 ± 3.43), (25.72 ± 1.76) vs. (36.05 ± 2.45) mm Hg (1 mm Hg = 0.133 kPa), P < 0.01; treatment protocol: (30.39 ± 3.17), (27.59 ± 1.99) vs. (40.68 ± 1.39) mm Hg, P < 0.01], reduced thickening of small pulmonary artery wall (P < 0.01) and right ventricular hypertrophy (P < 0.01). Rosuvastatin also inhibited PCNA expression of SMC (P < 0.01), restored eNOS expression of EC (P < 0.05) and inhibited ROCK-1 mRNA expressions in lung tissue (P < 0.05).Rosuvastatin therapy reduced mPAP in monocrotaline-induced pulmonary arterial hypertension rat model and this effect is linked with inhibition of ROCK-1 expression, inhibition of smooth muscle cell proliferation and restoration of endothelial cell functions." @default.
- W27008307 created "2016-06-24" @default.
- W27008307 creator A5015184699 @default.
- W27008307 creator A5018324533 @default.
- W27008307 creator A5022526821 @default.
- W27008307 creator A5073855401 @default.
- W27008307 date "2011-03-01" @default.
- W27008307 modified "2023-09-26" @default.
- W27008307 title "[Effects of rosuvastatin on monocrotaline-induced pulmonary artery hypertension in rats]." @default.
- W27008307 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21609531" @default.
- W27008307 hasPublicationYear "2011" @default.
- W27008307 type Work @default.
- W27008307 sameAs 27008307 @default.
- W27008307 citedByCount "2" @default.
- W27008307 countsByYear W270083072014 @default.
- W27008307 crossrefType "journal-article" @default.
- W27008307 hasAuthorship W27008307A5015184699 @default.
- W27008307 hasAuthorship W27008307A5018324533 @default.
- W27008307 hasAuthorship W27008307A5022526821 @default.
- W27008307 hasAuthorship W27008307A5073855401 @default.
- W27008307 hasConcept C126322002 @default.
- W27008307 hasConcept C126894567 @default.
- W27008307 hasConcept C134018914 @default.
- W27008307 hasConcept C164705383 @default.
- W27008307 hasConcept C2776390293 @default.
- W27008307 hasConcept C2777622882 @default.
- W27008307 hasConcept C2778326061 @default.
- W27008307 hasConcept C2779376020 @default.
- W27008307 hasConcept C2780499067 @default.
- W27008307 hasConcept C2780930700 @default.
- W27008307 hasConcept C2780940725 @default.
- W27008307 hasConcept C519581460 @default.
- W27008307 hasConcept C71924100 @default.
- W27008307 hasConceptScore W27008307C126322002 @default.
- W27008307 hasConceptScore W27008307C126894567 @default.
- W27008307 hasConceptScore W27008307C134018914 @default.
- W27008307 hasConceptScore W27008307C164705383 @default.
- W27008307 hasConceptScore W27008307C2776390293 @default.
- W27008307 hasConceptScore W27008307C2777622882 @default.
- W27008307 hasConceptScore W27008307C2778326061 @default.
- W27008307 hasConceptScore W27008307C2779376020 @default.
- W27008307 hasConceptScore W27008307C2780499067 @default.
- W27008307 hasConceptScore W27008307C2780930700 @default.
- W27008307 hasConceptScore W27008307C2780940725 @default.
- W27008307 hasConceptScore W27008307C519581460 @default.
- W27008307 hasConceptScore W27008307C71924100 @default.
- W27008307 hasIssue "3" @default.
- W27008307 hasLocation W270083071 @default.
- W27008307 hasOpenAccess W27008307 @default.
- W27008307 hasPrimaryLocation W270083071 @default.
- W27008307 hasRelatedWork W2020369764 @default.
- W27008307 hasRelatedWork W2041329079 @default.
- W27008307 hasRelatedWork W2044006442 @default.
- W27008307 hasRelatedWork W2347931505 @default.
- W27008307 hasRelatedWork W2350289237 @default.
- W27008307 hasRelatedWork W2351626409 @default.
- W27008307 hasRelatedWork W2354033534 @default.
- W27008307 hasRelatedWork W2354764819 @default.
- W27008307 hasRelatedWork W2362001172 @default.
- W27008307 hasRelatedWork W2365245589 @default.
- W27008307 hasRelatedWork W2370486249 @default.
- W27008307 hasRelatedWork W2371417344 @default.
- W27008307 hasRelatedWork W2374199279 @default.
- W27008307 hasRelatedWork W2377176572 @default.
- W27008307 hasRelatedWork W2377402056 @default.
- W27008307 hasRelatedWork W2389679717 @default.
- W27008307 hasRelatedWork W2437763898 @default.
- W27008307 hasRelatedWork W2973492468 @default.
- W27008307 hasRelatedWork W3029520661 @default.
- W27008307 hasRelatedWork W3029662510 @default.
- W27008307 hasVolume "39" @default.
- W27008307 isParatext "false" @default.
- W27008307 isRetracted "false" @default.
- W27008307 magId "27008307" @default.
- W27008307 workType "article" @default.